neostigmine has been researched along with Cognition Disorders in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JM | 1 |
| Mitsudome, A | 1 |
| Takeshita, K | 1 |
| Matsumoto, T | 1 |
| Duvoisin, RC | 1 |
| Katz, R | 1 |
3 other studies available for neostigmine and Cognition Disorders
| Article | Year |
|---|---|
Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Diso | 1975 |
[Crisis in myasthenia gravis in infancy and childhood].
Topics: Adolescent; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Deglutition Dis | 1971 |
Reversal of central anticholinergic syndrome in man by physostigmine.
Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Halluci | 1968 |